What is it about?
The treatment of newly diagnosed peripheral T-cell lymphoma
Featured Image
Why is it important?
The new regimen can increase the survival remarkably.
Read the Original
This page is a summary of: The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers, British Journal of Haematology, June 2017, Wiley,
DOI: 10.1111/bjh.14763.
You can read the full text:
Contributors
The following have contributed to this page
